Chargement en cours...
Bevacizumab in the treatment of HER2-negative breast cancer
Angiogenesis has a clear and definite role in the breast cancer progression process, making antivascular endothelial growth factor (VEGF) therapies an attractive option for the treatment of metastatic breast cancer (MBC). Bevacizumab is a potent humanized monoclonal antibody to VEGF, which has shown...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2008
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2727886/ https://ncbi.nlm.nih.gov/pubmed/19707460 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|